Spyre Therapeutics

SYRE

Börsenwert 9,9 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Jennison Associates New York	6,29 Mio. $	+121.184 $	+831	+1 %
2	2 OrbiMed New York	5,92 Mio. $	–	–	–
3	3 University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas	2,28 Mio. $	–	–	–
4	4 Rock Springs Capital Management Baltimore, Maryland	2,28 Mio. $	–	–	–
5	BBA 5 Baker Bros. Advisors New York	1,76 Mio. $	–	–	–
6	6 DAFNA Capital Management Los Angeles, California	1,52 Mio. $	–	–	–
7	7 VHCP Management II New York	1,52 Mio. $	–	–	–
8	8 Sio Capital Management New York	820.000 $	+199.203 $	+1.366	+22 %
9	9 Alyeska Investment Group Chicago, Illinois	521.000 $	+58.623 $	+402	+9 %
10	10 Perceptive Advisors New York	451.000 $	–	–	–
11	11 Norges Bank Oslo, Norway	275.000 $	–	–	–
12	12 Vanguard Group Malvern, Pennsylvania	239.000 $	+235.223 $	+1.613	+276 %
13	13 Geode Capital Management Boston, Massachusetts	101.000 $	+23.770 $	+163	+21 %
14	14 Lee Financial Dallas, Texas	97.000 $	+130.663 $	+896	Neu
15	15 Wells Fargo San Francisco, California	75.000 $	+84.435 $	+579	+517 %
16	16 BlackRock Fund Advisors San Francisco, California	60.000 $	+3.792 $	+26	+5 %
17	17 Spark Investment Management New York	52.000 $	+69.998 $	+480	Neu
18	18 Goldman Sachs New York	45.000 $	-132.121 $	-906	-69 %
19	19 VHCP Management New York	26.000 $	–	–	–
20	20 Morgan Stanley New York	12.000 $	-6.271 $	-43	-28 %
21	21 IFP Advisors Tampa, Florida	12.000 $	–	–	–
22	22 BlackRock Investment Management Wilmington, Delaware	4.000 $	–	–	–
23	23 UBS Group Zurich, Switzerland	3.000 $	-96.685 $	-663	-95 %
24	24 Acadian Asset Management Boston, Massachusetts	2.000 $	+2.771 $	+19	Neu
25	25 Tower Research Capital (TRC) New York	1.000 $	-2.917 $	-20	-71 %

Spyre Therapeutics SYRE Börsenwert 9,9 Mrd. $

Spyre Therapeutics

SYRE

Börsenwert 9,9 Mrd. $